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INTRODUCTION:  Pure  squamous  cell  carcinoma  of  the  breast  [SCCB]  is  rare.
PRESENTATION  OF  CASE:  We  report  a  case  of  primary  squamous  cell carcinoma  of  breast  with ipsilateral
axillary  lymph  node  metastasis  in a 58year  old  woman.vailable online 25 June 2011
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DISCUSSION:  It is  a breast  carcinoma  entirely  composed  of  metaplastic  squamous  cells  that  may  be ker-
atinized,  non-keratinized  or  spindled.  The  pure  squamous  cell  carcinoma  usually  present  with central
cystic  cavity,  which  we  found  in  our  case,  also  supported  by  immunohistochemical  evidence.
CONCLUSION:  Although  a rare  breast  cancer  subtype,  SCCB  is of considerable  interest  due  to  its  patholog-
ical  heterogeneity  and  differences  in  clinical  behavior  and  less  reported  occurrence  of  nodal  metastasis.
© 2
etastatic lymph node
. Introduction
Squamous cell carcinoma is a well known malignancy of the skin
nd other organs composed of squamous cells. Squamous cell car-
inoma of the breast is very rare. It is important to discriminate this
ntity from malignancies of the skin of the breast or metastasis of a
quamous cell carcinoma somewhere else in the body. In the liter-
ture only some small series are reported.1–3 Reported incidences
f primary squamous cell carcinoma of the breast vary between
.1% to less than 0.04% of all breast carcinomas.1–3 Clinical and
adiographic characteristics are not speciﬁc, and tumors are usually
ormone receptor negative. In general, these are very aggressive,
reatment-refractory tumors, with a poor prognosis. We  report a
ase of this rare breast malignancy with metastasis to ipsilateral
xillary lymph node and review the literature.
. Case report
.1. Clinical presentation
A 58-year-old, previously healthy female presented with a mass
n the right breast of four months duration. Physical examina-
ion revealed ﬁrm, non tender mobile lesion in her right breast
ith axillary lymphadenopathy. Mammography revealed a tumor
without microcalciﬁcations). Modiﬁed radical mastectomy with
xillary clearance was performed. The specimens demonstrated a
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cystic mass of 3 cm ×4 cm containing blood mixed necrotic mate-
rial [Fig. 1a]. HP section showed tumoural structure composed of
atypical keratinocytes in different sizes with narrow eosinophillic
cytoplasm and moderate mitotic activity on a background of
ﬁbrolipomatous breast stroma [Fig. 2a]. There was also presence
of a large central necrotic area [Fig. 1c]. In some areas abortive
pearl formation also was noted [Fig. 2c]. The overlying skin was
also unremarkable [Fig. 1a]. Estrogen receptors and progesterone
receptors were negative in tumor cells with positive internal con-
trol of normal ducts [Fig. 3]. Ipsilateral axillary lymph node showed
metastatic deposit of squamous cell carcinoma [Fig. 1d]. Metastatic
disease to the breast was  ruled out. CT scan thorax and abdomen
was  within normal limits. Other routine laboratory parameters at
the point of diagnosis were unremarkable. The patient had no his-
tory of skin cancer, nor did she have any skin, oral pharynx, or
anal lesions. According to all these ﬁndings the patient was  diag-
nosed with primary large cell keratinizing squamous cell carcinoma
[moderately differentiated] of the breast with metastasis to axil-
lary lymph node. After the operation patient suffered from severe
dyselectrolitemia for this she was kept in intensive care unit and
supportive treatment was given. On the 3rd post operative day
patient died due to cardio-respiratory failure.
3. Discussion
The histogenesis of this rare malignancy is unclear.4 Theories
Open access under CC BY-NC-ND license.include malignant growth of intrinsic epidermal elements (epider-
mal  or dermoid cysts) and metaplasia from breast parenchyma
(benign disease, e.g., cystosarcoma phylloides, ﬁbroadenomas, or
breast malignancies, e.g., intraductal carcinoma,) or from chronic
ense.
CASE  REPORT  –  OPEN  ACCESS
B. Mitra et al. / International Journal of Surgery Case Reports 2 (2011) 194– 197 195
F ize co
f t show
i c tum
a
d
m
(
m
F
cig. 1. [a] Gross picture of breast specimen having a cystic mass of 3 cm × 4 cm s
rom  tumor. Photomicrograph showing Tumoural area of breast with dilated duc
nﬂammatory cells, giant cells and lined by malignant squamous cells [c]. Metastati
bscess.5 Perhaps not surprisingly, these tumors have varying
egrees of homogeneity. A tumor is considered “pure SCC [Squa-
ous cell carcinoma]” if it meets Macia et al. criteria,6 including:
1) no other neoplastic components are present, such as ductal or
esenchymal elements in tumor, (2) the tumor is independent of
ig. 2. Photomicrograph showing tumor proper composed of atypical keratinocytes with
ells  having abundant eosinophillic cytoplasm and hyperchromatic pleomorphic nuclei [bntaining blood mixed necrotic material with attached skin grossly appeared free
ing squamoid metaplastic changes [b], cystic area containing necrotic material,
or within the lymph node [d] [H&E stain −40×].
adjacent cutaneous structures, (3) no other primary epidermoid
tumors are present in the patient (oral cavity bronchus, esophagus,
renal pelvis, bladder, ovary, and cervix).6,7
SCCB [Squamous cell carcinoma Breast] has been diagnosed in
adult women of ages ranging from 29 years to 90 years,8 with a
 moderate mitotic activity on a background of ﬁbrous breast stroma [a]. Individual
] with abortive squamous pearl formation. [c] [H&E stain 40×].
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dFig. 3. Photomicrograph showing tumoural area with estrogen and progestero
edian of 52 years of age.9 In contrast to most breast cancers these
umors are unusually rapidly growing. Patients typically report
 breast mass that enlarged over a period of 2–3 weeks, or in
ome cases for as long as 18 months.4,8 Primary tumors tend to
e relatively large (range 2–5 cm,  median 4 cm).4,10 Our case was
8-year-old with duration of the disease four months, which is sup-
orted by literature. Approximately two thirds of these tumors are
ystic or have a cystic component with central necrosis7,9 which we
ound in our case. Axillary lymph node metastasis occurs rarely and
hen it does is usually associated with metaplastic SCCB arising in
n invasive ductal carcinoma and we have no such evidence in our
ase though it showed ipsilateral axillary lymph node metastasis.
Estrogen and progesterone receptors are negative in more than
0% of the cases of pure SCCB8,11,12 which was also proven in our
ase. The only case of HER-2/neu over expression in SCCB was
eported by Karamouzis et al.11 There is only one reported case
f a BRCA 1 gene mutation in a patient with SCCB.12
SCCB does not have characteristic mammographic features.
ome tumors have been reported to have irregular, indistinct
orders, whereas others have been reported to have well cir-
umscribed borders.13 The most consistent feature of SCCB on
ammogram is the lack of microcalciﬁcations.4 Only one reported
ase of SCCB has shown microcalciﬁcations on mammogram.14
ur case followed the norm by not showing microcalciﬁcations on
ammogram.
Prognosis appears to be dependent upon several factors, most
mportantly tumor size and tumor stage.13 The SEER database from
988 to 2001 included 137 cases of SCCB with a 5-year survival rate
f 64%.1
The initial management of SCCB is modiﬁed radical mastectomy
ith adjuvant radiotherapy and or chemotherapy/hormonal ther-
py. Breast conservation therapy is not usually possible because
ost patients present with locally advanced disease.15,16 Because
quamous cell cancers are often radiosensitive Hennessy et al.
roposed early adjuvant radiotherapy despite being unable to
emonstrate a difference (presumably because of small numbers)eptor negativity [a and b] [10×] with positive internal control [c and d] [40×].
in the loco-regional relapse-free rate of 45% among those receiv-
ing vs 33% among those not receiving radiotherapy.15 Adjuvant and
neoadjuvant chemotherapy regimens used at M.D. Anderson Can-
cer Center include 5-ﬂourouracil alone, 5-ﬂourouracil/cisplatin, 5-
ﬂourouracil/taxane, 5-ﬂourouracil/cisplatin followed by pacitaxel,
and cyclophosphamide plus methotrexate plus luorouracil.15,16
Hennessy et al. reported no beneﬁt to neoadjuvant therapy.15
4. Conclusion
Squamous cell carcinoma of the breast is a rare, gener-
ally aggressive disease associated with locoregional and distant
relapses. Current surgical management is similar to that for the
more common adenocarcinoma. However because effective adju-
vant or neoadjuvant therapy is not available, future research should
focus on the molecular biology, (e.g., epidermal growth factor
receptor), to develop tumor-speciﬁc therapy.
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